Home Comparison of the effectiveness of nurse-led preoperative counseling and postoperative follow-up care vs standard care for patients with gastric cancer
Article Open Access

Comparison of the effectiveness of nurse-led preoperative counseling and postoperative follow-up care vs standard care for patients with gastric cancer

  • Wenwen Wang ORCID logo , Yan Zhu ORCID logo , Yu Sun ORCID logo and Yandong Li ORCID logo EMAIL logo
Published/Copyright: January 17, 2025

Abstract

Background

Radical gastrectomy is generally prefered for gastric cancer but has postoperative complications. The objectives of the study are to evaluate the effectiveness of three different models of preoperative counseling and postoperative follow-up care in patients who underwent radical gastrectomy for gastric cancer.

Methods

In retrospective medical record analyses, patients received nurse-led preoperative counseling and postoperative follow-up care (NC cohort, n = 105) or surgeon-led preoperative counseling and surgeon-led follow-up (SC cohort, n = 140), or did not receive counseling and aftercare (RC cohort, n = 160).

Results

Patients had a postoperative intensive care unit (PICU) stay of 24 (26–22) h/patient and postoperative pain of 6 (6–5)/ patient. The frequencies of nausea, vomiting, medical intensive care unit admission(s), dizziness, length of PICU stay, and intensity of postoperative pain were lower among patients in the NC cohort, followed by those in the SC and RC cohorts. A higher number of patients in the RC cohort died when compared to the NC (25 [16%) vs 2 [2%], p = 0.0458) and the SC (25 [16%] vs 11 [8%], p = 0.0001) cohorts in follow-up.

Conclusion

Patients who undergo radical gastrectomy for gastric cancer require healthcare professional-led preoperative counseling and postoperative aftercare. Nurse-led preoperative counseling and postoperative aftercare, could improve outcome measures in patients who underwent radical gastrectomy for gastric cancer.

Graphical abstract

1 Introduction

More than one million new cases of gastric cancer were reported worldwide in 2020. In addition, half of all cancer patients in China have gastric cancer [1]. Because of the diet conditions of the Chinese population, the number of patients with gastric cancer is higher in the Chinese population than in the Australian, American, or European populations [2]. Radical gastrectomy is generally preferred in patients with gastric cancer [3]. However, postoperative complications and mortality are frequent due to issues associated with the radical gastrectomy procedure [4]. Postoperative complications of radical gastrectomy are quite common, and some are rare, but they have a clinical impact in practice [5,6]. Postoperative complications for radical gastrectomy cause poor prognosis, and patients may have a longer hospital stay [7]. By managing the frequency of postoperative complications for radical gastrectomy, it is possible to improve prognosis and reduce the length of hospital stay and mortality events in patients with gastric cancer after a gastrectomy procedure [7].

Preoperative therapies and/or aftercare also have a positive impact on postoperative prognosis, length of hospital stay, and mortality in patients with gastric cancer after radical gastrectomy [8,9]. Moreover, preoperative instructions to patients before surgery decrease their anxieties and cancellation of surgeries [10]. Nurse-led care is more cost-effective and has a positive effect on postoperative prognosis than consultant-led care [11]. Moreover, a retrospective study [12] reported that nurse-supervised exercises at the institute are associated with a decreased frequency of complications that cause rehospitalization and death in patients with acute pancreatitis.

The objectives of this retrospective study are to evaluate the frequencies of postoperative complications, length of hospital stay, and number of death events in the northeast region of China among patients with gastric cancer who underwent radical gastrectomy and received preoperative nurse-led counseling and postoperative nurse-led follow-up care against standard care (preoperative surgeon-led counseling and postoperative surgeon-led aftercare) against those who did not receive preoperative health professional-led counseling before radical gastrectomy and received only surgeons visit every 3 months.

2 Materials and methods

2.1 Research design

The research design consists of a retrospective study using patients’ medical records.

2.2 Inclusion criteria

Patients (aged ≥18 years or more) who underwent elective radical gastrectomy (laparoscopy or laparotomy) were included in the study.

2.3 Exclusion criteria

Patients with cognitive impairments and those with records of three or more vital parameters missing from the patients’ records of the institute(s) were excluded from the analyses.

2.4 Sample size calculations

The statistical analyses for sample size calculation were carried out using the XLSTAT trial version, Excel Statistical Software, Addinsoft, New York, NY, USA, and based on the assumption that the incidence of postoperative immediate and late complications and/or mortality of patients who underwent radical gastrectomy would be decreased 10% with preoperative healthcare professional-led counseling and postoperative professional-led care than those who did not receive preoperative healthcare professional-led counseling before radical gastrectomy and received surgeons visit in follow-up at every 3 months, 5% margin of error(s), 95% confidence interval (CI), and 10% of standard deviation (SD), the sample size (minimum patients required in a cohort) would be 105. Kruskal–Wallis’ test was used for the sample size calculation.

2.5 Cohorts

A total of 105 patients received preoperative nurse-led counseling, postoperative nurse-led follow-up care between chemoradiotherapy and follow-up after radical gastrectomy, and surgeon(s) visits every 3 months during follow-up (NC cohort). A total of 140 patients received preoperative surgeon-led counseling before radical gastrectomy, and the surgeon(s) visited every 3 months between chemoradiotherapy and during follow-up after radical gastrectomy (SC cohort). A total of 160 patients did not receive preoperative surgeon-led counseling before radical gastrectomy and underwent surgeon(s) visits every 3 months between chemoradiotherapy and during follow-up after radical gastrectomy (RC cohort). The selection of healthcare professional-led care was based on the availability of professionals in the institutes and choice of patients. Availability was based on empty appointment spots in the future (patient could wait for 1 or 2 weeks).

2.6 Details about the operation method

All the enrolled cases are advanced upper one-third or esophageal gastric junction cancers and all cases in the cohort underwent total gastrectomy. Mostly patients underwent subtotal or the extent of lymph node dissection, and the gastrointestinal reconstruction method was used.

2.7 Non-treatment interventions

2.7.1 Preoperative nurse-led counseling and postoperative nurse-led follow-up care

Preoperative nurse-led counseling included a discussion of the risks and benefits of radical gastrectomy, including cost factors for patients and caregivers. The nurse used visual aids to describe the situation after surgery. Postoperative nurse-led care included visits by nurses every 15 days. The surgeon visits the institute every 3 months. Postoperative nurse-led follow-up care included aftercare regarding postoperative adverse effects and mortality, including education and instructions for food habits. The duration of the visit of the surgeon(s) and nurse(s) was a maximum of 30 min. However, they were available via phone calls.

2.7.2 Standard care (preoperative surgeon-led counseling and postoperative surgeon-led care)

Preoperative surgeon-led counseling included a discussion of the risks and benefits of radical gastrectomy with patients and caregivers. Postoperative surgeon-led care included visits by the surgeon(s) at the institute every 3 months. Postoperative surgeon-led care included care regarding postoperative adverse effects and mortality, including education and instructions regarding food habits. The maximum length of visits by the surgeon(s) was 30 min. However, they were available via phone calls.

Patients in the RC cohort received literature on postoperative care. The selection of patients in the NC, SC, and RC cohorts was based on the availability of professionals in the institute. Patients in the NC and SC cohorts received healthcare professional-led aftercare for a minimum of 6 months.

2.8 Outcome measures

2.8.1 Demographic and clinical parameters

Demographic, clinical, treatment, and surgery-related parameters were extracted from the patients’ medical records and analyzed.

2.8.2 Postoperative complications

After surgery, immediate and delayed postoperative complications in the postoperative intensive care unit (PICU), ward, and follow-up of 6 months were collected from the hospital records of patients and analyzed. Clavien-Dindo classification method was preferred for evaluation of immediate complications after radical gastrectomy [13].

2.8.3 PICU stays

From completion of operation to transfer to ward.

2.8.4 Total hospital stays

After completion of the operation to discharge of patient.

2.8.5 Death

The death of patient due to any reason(s) was considered death (mortality) during 18 months of follow-up.

2.8.6 Clinical benefits for healthcare professional-led counseling and professional-led aftercare

The clinical benefits of healthcare professional-led counseling and aftercare of patients who underwent radical gastrectomy for gastric cancer were evaluated as a function of the beneficial scores. Beneficial scores for healthcare professional-led counseling and healthcare professional-led aftercare were calculated from the risk of undercare, as expressed in equation (1). The risk of undercare was defined by a calculation that involved the incidence of immediate and late postoperative complications and/or mortality of patients who underwent radical gastrectomy for gastric cancer (equation (2)). The confidence for radical gastrectomy for gastric cancer was considered a numerical value from 0 to 1. The beneficial score of the healthcare professional-led counseling and healthcare professional-led aftercare is the area above the curve of the counseling and care adopted, and the working area is the area under the curve of the adopted counseling and care methods. For all adopted counseling and aftercare, 10% or more of differences in the incidence of postoperative immediate and late complications and/or mortality of patients (with respect to patients of the RC cohort) were used as the reference standard [14].

(1) Beneficial score = Number of patients with 10 % or more of the differences in the incidence of postoperative immediate and late complication and / or mortality Total number of patients Number of patients with less than 10 % of the differences in the incidence of postoperative immediate and late complication and / or mortality Total number of patients × Risk of under care ,

(2) Risk of under care = The differences in the incidence of postoperative immediate and late complication and / or mortality 100 the differences in the incidence of postoperative immediate and late complication and / or mortality .

2.9 Statistical analysis

InStat 3.01 GraphPad Software (San Diego, CA, USA) was used for the statistical analysis. Calculator Soup® (https://www.calculatorsoup.com/calculators/statistics/quartile-calculator.php) was used to calculate the quartile values. Normally distributed continuous variables, non-normally distributed continuous variables, and categorical variables are presented as mean values ± SD, medians (Q3–Q1), and frequencies (percentages), respectively. The Kolmogorov and Smirnov methods were used to check the normality of continuous variables or data. The unpaired t-test, paired t-test, or one-way analysis of variance (ANOVA) was preferred for normally distributed continuous variables. For non-normally distributed continuous variables, the non-parametric Wilcoxon test, Mann–Whitney U test, or Kruskal–Wallis’ test was used. Dunn’s test was used for post hoc analysis of non-normally distributed continuous variables. Tukey’s test was used for post hoc analysis of normally distributed continuous variables. Bartlett’s test was used to check assumption of unpaired t-test and ANOVA. Levene’s test was used for homogeneity of variances for Wilcoxon signed-rank test. The chi-square test or Fisher’s exact test was preferred for statistical analyses of categorical variables. Multivariate analyses (logistic regression analyses) were performed to evaluate the association between demographic and clinical parameters and worse postoperative complications in patients [8]. All results were considered significant if the p-value was less than 0.05 at 95% CI.

  1. Ethical approval: The protocols for retrospective medical record analyses were designed by the authors themselves and approved by the Beihua University review board (Approval number YDZJ202201ZYTS156 dated January 15, 2020) and the Chinese Anti-Cancer Association. The study followed the law of China and the v2008 Declarations of Helsinki.

  2. Informed consent: Consent to participate was waived by the Beihua University review board because of the retrospective medical record analyses.

3 Results

3.1 Study population

From January 15, 2020 to July 31, 2022, a total of 415 patients with gastric cancer underwent radical gastrectomy at the Affiliated Hospital of Beihua University, Jilin City, Jilin Province, China, and the referring hospitals. Among them (415 patients), three patients had cognitive impairments, and three or more vital parameters were missing from the hospital patient records of seven patients. Therefore, the data from these ten patients were excluded from the analyses. Data on postoperative complications, PICU stay, total hospital stay, and death in 405 patients who underwent radical gastrectomy for gastric cancer were included in the study. A chart of the retrospective medical record analysis is presented in Figure 1.

Figure 1 
                  The chart of retrospective medical record analyses. PICU: Postoperative intensive care unit, MICU: Medical intensive care unit. Red color indicates worse parameters. Black color indicates not good but not worse parameters.
Figure 1

The chart of retrospective medical record analyses. PICU: Postoperative intensive care unit, MICU: Medical intensive care unit. Red color indicates worse parameters. Black color indicates not good but not worse parameters.

3.2 Demographic and clinical parameters

A total of 73% of patients were male. Patients in the range of 48–63 years were included in the analyses. Most of the patients were Han Chinese. One-third of radical gastrostomies were laparoscopies. Only 12% of patients received neoadjuvant chemotherapy. The surgery time was between 150 and 208 min/patient. The body mass index (BMI) of the patients was between 24 and 25.8 kg/m2. Sex, age, ethnicity, nature of gastrectomy, preference for chemotherapy, BMI, and surgery time for patients were comparable among cohorts (p > 0.05 for all). The demographic and clinical parameters are reported in Table 1. All patients included in the study were subjected to adjuvant therapy.

Table 1

Demographic, clinical, and surgical parameters of the enrolled patients

Parameters Total Cohorts
NC SC RC Comparison between cohorts
Professional-led Care Preoperative nurse-led counseling and postoperative nurse-led follow-up care Preoperative surgeon-led counseling and postoperative surgeon visits in follow-up Follow-up surgeons’ visits/3 months only
Number of patients 405 105 140 160 p-value df Test value
Gender
Male 295 (73) 70 (67) 105 (75) 120 (75) 0.2554 (χ 2-test for independence) 2 2.73
Female 110 (27) 35 (33) 35 (25) 40 (25)
Age (years) 54 (59–51) 54 (58–51) 55 (60–51) 54 (59–51) 0.1059 (Kruskal–Wallis’ test) N/A 4.49
Ethnicity
Han Chinese 371 (92) 96 (91) 129 (92) 146 (91) 0.9955 (χ 2-test for independence) 4 0.1951
Mongolian 31 (7) 8 (8) 10 (7) 13 (8)
Tibetan 3 (1) 1 (1) 1 (1) 1 (1)
Nature of gastrectomy
Laparoscopy 150 (37) 40 (38) 50 (36) 60 (38) 0.9184 (χ 2-test for independence) 2 0.1702
Laparotomy 355 (63) 65 (62) 90 (64) 100 (62)
Neoadjuvant chemotherapies
Yes 49 (12) 11 (10) 17 (12) 21 (13) 0.8111 (χ 2-test for independence) 2 0.4186
No 356 (88) 94 (90) 123 (88) 139 (87)
Surgery time (min) 186 (195–170) 178 (190.5–170) 188 (196–169.5) 187 (195.5–168) 0.1454 (Kruskal–Wallis’ test) N/A 3.586
BMI (kg/m2) 25.7 (26–24.9) 25.5 (25.9–24.8) 25.8 (26–25) 25.8 (26–25) 0.1082 (Kruskal–Wallis’ test) N/A 4.447
Education
Primitive 69 (17) 24 (23) 22 (16) 23 (14) 0.2688 (χ 2-test for independence) 6 7.601
Up to higher secondary 180 (44) 36 (34) 65 (46) 79 (49)
Higher secondary but below graduate 116 (29) 32 (30) 41 (29) 43 (27)
Graduate or more 40 (10) 13 (13) 12 (9) 15 (10)

Non-normal distributed continuous variables and constant variables are depicted as medians (Q3–Q1) and frequencies (percentages).

All results were considered significant if the p-value was less than 0.05 at 95% CI.

df: Degree of freedom, N/A: not applicable, BMI: Body mass index, CI: confidence interval.

Test value (χ 2-value for χ 2-test; Kruskal–Wallis’ statistics for Kruskal–Wallis’ test).

3.3 Outcome measures

3.3.1 Postoperative complications

The number of patients with nausea, vomiting, medical intensive care unit (MICU) admission(s), dizziness, PICU stays, and postoperative pain was fewer among patients of the NC cohort followed by patients of the SC and those of the RC cohorts. The PICU stay was 24 (26–22) h/patient. Postoperative pain was 6 (range, 6–5) per patient. Rare serious early postoperative complications were reported among patients. Details of early postoperative complications are reported in Table 2. Late postoperative complications were reported in patients in all cohorts. There were one, and only one patient with each type of late complication in the NC cohort and seven patients in the RC cohort except eight with pancreatic fistula and internal hernia. There were statistically insignificant differences in each of the late postoperative complications among the patients in all cohorts. However, the number of patients with late postoperative complications was lower among patients in the NC cohort, followed by patients in the SC and RC cohorts. None of the patients reported gastroparesis. Details of the late postoperative complications are reported in Table 3.

Table 2

Immediate complications after radical gastrectomy

Cohorts
Events RC NC SC
Care Follow-up surgeons’ visits/3 months only Preoperative nurse-led counseling and postoperative nurse-led follow-up care Comparison between the RC and the NC cohorts Preoperative surgeon-led counseling and postoperative surgeon visits in follow-up Comparison between the RC and the SC cohorts Comparison between the SC and the NC cohorts
Number of patients 160 105 p-value Test value 95% CI 140 p-value Test value 95% CI p-value Test value 95% CI
Number of patients with nausea 25 (16) 2(2) 0.0001 (Fisher exact test) 1.632 1.399–1.904 11 (8) 0.0495 (Fisher exact test) 1.358 1.061–1.738 0.0458 (Fisher exact test) 0.3465 0.09603–1.250
Number of patients with vomiting 18 (11) 0 (0) <0.0001 (Fisher exact test) 1.739 1.563–1.936 6 (4) 0.0324 (Fisher exact test) 1.458 1.126–1.887 0.0389 (Fisher exact test) 0 −Infinite to +Infinite
Number of patients required MICU admission(s) 20 (13) 0 (0) <0.0001 (Fisher exact test) 1.75 1.570–1.95 7 (5) 0.0264 (Fisher exact test) 1.444 1.123–1.857 0.021 (Fisher exact test) 0 −Infinite to +Infinite
PICU stay (hours) 26 (27.5–25) 22 (23–21) <0.001 (Kruskal–Wallis’ test/Dunn’s test) 272.83 N/A 24 (24–23) <0.001 (Kruskal–Wallis’ test/Dunn’s test) 272.83 N/A <0.001 (Kruskal–Wallis’ test/Dunn’s test) 272.83 N/A
Number of patients with dizziness 9(6) 1(1) 0.0943 (Fisher exact test) 1.52 1.207–1.914 4(3) 0.2705 (Fisher exact test) 1.316 0.9010–1.922 0.3955 (Fisher exact test) 0.4615 0.07945–2.681
Postoperative pain 6 (7–5) 4 (5–4) <0.001 (Kruskal–Wallis’ test/Dunn’s test) 131.82 N/A 6 (7–6) <0.001 (Kruskal–Wallis’ test/Dunn’s test) 131.82 N/A <0.001 (Kruskal–Wallis’ test/Dunn’s test) 131.82 N/A
Number of patients with fever 5 (3) 2 (2) 0.7068 (Fisher exact test) 1.189 0.7364–1.920 2 (2) 0.455 (Fisher exact test) 1.35 0.8347–2.184 <0.0001 (Fisher exact test) 68.667 17.334–272.01
Number of patients with dumping syndrome 1 (1) 1 (1) 0.9999 (Fisher exact test) 0.827 0.2061–3.319 1(1) 0.9999 (Fisher exact test) 0.9371 0.2333–3.764 0.9999 (Fisher exact test) 1.168 0.2899–4.709
Number of patients with aspiration pneumonia 1 (1) 1 (1) 0.9999 (Fisher exact test) 0.827 0.2061–3.319 1(1) 0.9999 (Fisher exact test) 0.9371 0.2333–3.764 0.9999 (Fisher exact test) 1.168 0.2899–4.709
Number of patients with septic shock 1 (1) 1 (1) 0.9999 (Fisher exact test) 0.827 0.2061–3.319 1 (1) 0.9999 (Fisher exact test) 0.9371 0.2333–3.764 0.9999 (Fisher exact test) 1.168 0.2899–4.709

Non-normal variables and ordinal data are depicted as medians (Q3–Q1). Categorial variables are depicted as frequencies (percentages).

All results were considered significant if the p-value was less than 0.05 at 95% CI (using the approximation of Katz for categorical variables).

df: Degree of freedom, N/A: not applicable, CI: confidence interval, MICU: Medical intensive care unit, PICU: Postoperative surgical care unit, In: Infinity.

Test value (χ 2-value for χ 2-test; relative risk for Fisher exact test).

A visual analog scale was used to evaluate postoperative pain (evaluated 1 day after surgeries; 0: absent pain, 10: worst possible pain).

Table 3

Late complications after radical gastrectomy

Cohorts
Events RC NC SC
Care Follow-up surgeons’ visits/3 months only Preoperative nurse-led counseling and postoperative nurse-led follow-up care Comparison between the RC and the NC cohorts Preoperative surgeon-led counseling and postoperative surgeon visits in follow-up Comparison between the RC and the SC cohorts Comparison between the SC and the NC cohorts
Number of patients 160 105 p-value RR 95% CI 140 p-value RR 95% CI p-value RR 95% CI
Number of patients with duodenal stump fistula 7 (4) 1 (1) 0.1517 1.47 1.110 –1.946 2 (1) 0.1819 1.479 1.026 –2.133 0.9999 0.7756 0.1555–3.870
Number of patients with pancreatic fistula 8 (5) 1 (1) 0.092 1.479 1.163 –1.927 3 (2) 0.2295 1.383 0.9474–2.018 0.6373 0.5793 0.1054–3.184
Numbers of patients with chyle leakage 7 (4) 1 (1) 0.1517 1.47 1.110 – 1.946 4 (3) 0.5515 1.202 0.7589–1.904 0.3955 0.4615 0.07945–2.681
Number of patients with esophagomediastinal fistula 7 (4) 1 (1) 0.1517 1.47 1.110–1.946 2 (1) 0.1819 1.479 1.026–2.133 0.9999 0.7756 0.1555–3.870
Number of patients with internal hernia 8 (5) 1 (1) 0.092 1.479 1.163–1.927 3 (2) 0.2295 1.383 0.9474–2.018 0.6373 0.5793 0.1054–3.184
Number of patients with small bowel paresis 7 (4) 1 (1) 0.1517 1.47 1.110–1.946 4 (3) 0.5515 1.202 0.7589–1.904 0.3955 0.4615 0.07945–2.681
Number of patients with intussusception 7 (4) 1 (1) 0.1517 1.47 1.110–1.946 2 (1) 0.1819 1.479 1.026–2.133 0.9999 0.7756 0.1555–3.870

Variables are depicted as frequencies (percentages).

Fisher exact test was used for statistical analysis.

All results were considered significant if the p-value was less than 0.05 at 95% CI.

df: Degree of freedom, N/A: not applicable, CI: confidence interval, RR: Relative risk.

3.3.2 Total hospital stays

A total of 8 (9–7) days/patient, 9 (10–7) days/patient, and 9.5 (12–8) days/patient were the total length of hospital stays for patients of the NC, SC, and RC cohort, respectively. The total length of hospital stays for patients in the NC cohort were lesser than those of patients in the SC and RC cohorts (p < 0.001 for both, Kruskal–Wallis’ test/Dunn’s test). The total hospital stay for patients in the SC and RC cohorts was statistically similar (p > 0.05, Kruskal–Wallis’ test/Dunn’s test). The details of the total length of hospital stay of the patients are shown in Figure 2.

Figure 2 
                     Total hospital stays of patients. Total hospital stays: After completion of operation to discharge of patients. Upper whisker: maximum value, upper box line: third quartile value, x: median value, lower box line: first quartile value, lower whisker: minimum value. *: Fewer than those of patients of the SC and RC cohorts.
Figure 2

Total hospital stays of patients. Total hospital stays: After completion of operation to discharge of patients. Upper whisker: maximum value, upper box line: third quartile value, x: median value, lower box line: first quartile value, lower whisker: minimum value. *: Fewer than those of patients of the SC and RC cohorts.

3.3.3 Death

A total of 2 (2%), 11 (8%), and 25 (16%) patients in the NC, SC, and RC cohorts, respectively, died due to some reason(s) during the 18 months of follow-up. During the 18-month follow-up period, a higher number of patients in the RC cohort died for several reasons than those in the NC (25 [16%] vs 2 [2%], p = 0.0458, Fisher exact test) and the SC (25 [16%] vs 11 [8%], p = 0.0001, Fisher exact test) cohorts. During the 18-month follow-up period, a higher number of patients in the SC cohort died for several reasons than those in the NC cohort (p = 0.0495, Fisher exact test).

3.3.4 Independent parameters for worse postoperative complications

The absence of neoadjuvant chemotherapy (p = 0.049, logistic regression analysis) was associated with worse postoperative complications and death. The details of the association of demographic and clinical parameters with worse postoperative complications in patients are presented in Table 4.

Table 4

Multivariate analyses association of the demographic and clinical parameters with worse postoperative complications of patients

Parameter Odds ratio % CI p-value
Gender (female vs male) 0.8142 0.7214–0.8421 0.5621
Age (≥60 years vs <60 years) 0.3254 0.2245–0.3824 0.0821
Nature of gastrectomy (laparoscopy vs laparotomy) 0.7745 0.6541–0.8142 0.3224
Neoadjuvant chemotherapies (*No vs yes) 1.4521 1.2141–2.1451 0.049
Surgery time (<200 min vs ≥200 min) 0.9341 0.8142–0.9522 0.0651
BMI (>25 vs ≤25) 0.6654 0.5142–0.8422 0.062

BMI: Body mass index, CI: Confidence interval.

*Significant parameter, p value less than 0.05, and odds ratio more than 1 considered significant.

3.3.5 Clinical benefits for healthcare professional-led counseling and professional-led aftercare

The beneficial score for patients of the NC cohort had 10–80.8% differences in the incidence of postoperative immediate and late complications and/or mortality, whereas SC cohort had 10–20% differences in the incidence of postoperative immediate and late complications and/or mortality, and RC cohort had no beneficial score for counseling and aftercare for gastric cancer. Above 80.8, 20, and 0% differences in the incidence of postoperative immediate and late complications and/or mortality of patients of the NC, SC, and RC cohorts had the risk of undercare, respectively. The details of the clinical benefits of healthcare professional-led counseling and healthcare professional-led aftercare are presented in Table 5. The graphical presentation of the clinical benefits of healthcare professional-led counseling and healthcare professional-led aftercare are presented in Figure 3.

Table 5

Beneficial score analyses

% differences in the incidence of postoperative immediate and late complication and/or mortality from the RC cohort patients Cohorts
NC cohort SC cohort RC cohort
Professional-led care Preoperative nurse-led counseling and postoperative nurse-led follow-up care Preoperative surgeon-led counseling and postoperative surgeon visits in follow-up Follow-up surgeons’ visits/3 months only
Numbers of patients 105 140 160
0 0.87 0.21 0
5 0.86 0.17 −0.05
10 0.85 0.12 −0.11
15 0.84 0.07 −0.18
20 0.83 0.01 −0.25
25 0.82 −0.06 −0.33
30 0.81 −0.13 −0.43
40 0.78 −0.32 −0.67
50 0.73 −0.59 −1
65 0.62 −1.27 −1.86
80 0.33 −2.96 −4
99 −12.33 −78.29 −99
Beneficial score (% differences in the incidence of postoperative immediate and late complication and/or mortality from the RC cohort patients) 11–80.8% 10–20% None
Risk of undercare (% differences in the incidence of postoperative immediate and late complication and/or mortality from the RC cohort patients) >80.8% >20% >0%

Effect size: 10% differences in the incidence of postoperative immediate and late complication and/or mortality compared from the RC cohort patients.

Figure 3 
                     The clinical benefits for healthcare professional-led counseling and healthcare professional-led aftercare.
Figure 3

The clinical benefits for healthcare professional-led counseling and healthcare professional-led aftercare.

4 Discussion

Patients who underwent radical gastrectomy for gastric cancer had considerable postoperative immediate and delayed complications, PICU stays, and requirements of hospital stays, and death events of patients were also reported in the follow-up of 18 months. The results of the current retrospective medical record analyses were consistent with those of a retrospective review of the Chinese population [7]. Patients who undergo radical gastrectomy for gastric cancer require preoperative healthcare professional-led counseling and postoperative follow-up care.

Immediate postoperative complications were reported to be fewer in the NC and SC cohorts than in the RC cohort. The results of immediate postoperative complications of the current retrospective medical record analyses are consistent with those of a retrospective review of the Chinese population [7], a randomized trial [15], and a systematic review [16]. Preoperative counseling by healthcare professionals decreases immediate postoperative complications in gastric surgery [15]. Preoperative counseling by a healthcare professional is necessary in patients who have undergone radical gastrectomy for gastric cancer.

Late surgical complications were observed across the cohorts. The results of late postoperative complications of the current retrospective medical record analyses are consistent with those of a retrospective review of the Chinese population [7]. Late postoperative complications are mainly due to the surgery itself, patient profile, and other comorbidities [5,6]. Several late postoperative complications are rare. In particular, intussusception has not been observed after upper gastrointestinal resection. Additionally, chyle leakage and internal hernias are rare. In any case, these late postoperative complications are highly related to what has been done during the surgery and are rarely related to counseling or lack thereof [17]. The experience and expertise of surgeons and different surgical techniques could lead to a decrease in late postoperative complications in patients after radical gastrectomy for gastric cancer.

The length of total hospital stay was reported to be higher in the RC cohort. Postoperative complications and their treatments increased the length of total hospital stay of patients undergoing gastric surgery [18]. Professional-led preoperative care, especially nurse-led counseling and postoperative follow-up care, could reduce total hospital stays.

During the follow-up period, fewer patients in the NC and SC cohorts, especially in the NC cohort, died for several reasons. The mortality results of the current retrospective medical record analyses are consistent with a retrospective review of the Chinese population [7], meta-analyses [5,6], and literature reviews [18]. Fewer postoperative complications would lead to fewer deaths in patients after gastric surgeries [18]. In addition, age, surgeries, severity of diseases, and present comorbidities are associated with the death of patients after radical gastrectomy [19]. By reducing postoperative complications and improving the experience and expertise of multidisciplinary approaches and teamwork, including surgeons(s), there is hope to decrease the death of patients who have undergone radical gastrectomy for gastric cancer. The details of the comparative studies on nurse-led aftercare for cancer patients undergoing gastric surgeries/oncology surgeries in different settings are presented in Table 6.

Table 6

Comparative studies on nurse-led aftercare for cancer patients undergoing gastric surgeries/oncology surgeries in different settings

Study Published year Study population Sample size (N; patients) Age (years) Follow-up
Meta-analysis, Guerra et al. [5] 2018 Patients underwent minimally invasive radical gastrectomy 2,000 55–74 years 1–6 months
Retrospective review, Yan et al. [7] 2023 Chinese gastric cancer patients underwent radical gastrectomy 891 (432/461) 62.65 ± 10.62/63.22 ± 11.66 6 months
Randomized trial, Verschuur et al. [11] 2009 Dutch patients after intentionally curative surgery for esophageal or gastric cardia cancer 109 (54/55) 61 ± 7; 61 ± 9 13 months
Retrospective analysis, Huang and Zhang [12] 2024 Chinese patients with acute pancreatitis 381 (123/103/155) 55 (60–50) 6 months
Randomized trial, Samnani et al. [15] 2014 Pakistani patients underwent abdominal surgery 232 (1,131/111) 36.7 ± 8.69/ 37.01 ± 8.43 1 month
Post-study analyses, Stratilatovas et al. [19] 2015 Lithuanian patients underwent gastrectomy for gastric cancer 1,674 >18 years 10 years

The absence of neoadjuvant chemotherapy (p = 0.049) was associated with worse postoperative complications and death. Patients' willingness or family decisions regarding chemotherapy: Typically, almost all patients with gastric cancer undergo neoadjuvant chemotherapy. However, in the current study, only 12% patients received neoadjuvant therapy. Notably, many diseases, including cancer and gastric cancer, require a multidisciplinary approach and teamwork. At present, we have to consider confounding factors (as mentioned in the results section) for worse postoperative complications.

Gastroparesis was not reported in any of the patient. The patients have all had total gastrostomies. Therefore, they have no stomach involved and cannot have gastroparesis.

This study has several limitations, such as non-randomized, non-intervention(s), retrospective analyses, and lack of controlled trials. This is unfortunate because the basic hypothesis is relevant, although a randomized controlled trial would have been ideal. However, at the current state of knowledge in the care of gastric cancer patients, a corresponding study design can be of value to generate a baseline platform for conducting a future randomized controlled trial. The psychological conditions of the patients, stage of cancer, type of cancer, site of the tumor, presence of metastasis, and comorbidities, etc., were not evaluated, which could influence the outcomes. For instance, T4 tumors may increase the difficulty of the operation and might induce a higher risk of complications. Patients undergoing neoadjuvant therapy comprised a small group. In nurse-led preoperative counseling cohort patients had surgery without a surgeon describing the operation. This is unusual.

5 Conclusion

The current study was a retrospective study on nurse-led vs surgeon-led vs no preoperative counseling and outcomes in gastric cancer surgery. A total of 405 patients who underwent radical gastrectomy for gastric cancer were included, and the main result was that nurse-led preoperative counseling was associated with fewer symptoms, pain, hospital stay, and mortality compared to other methods. Patients who undergo radical gastrectomy for gastric cancer require preoperative healthcare professional-led counseling and healthcare professional-led follow-up care. Preoperative healthcare professional-led care, especially nurse-led counseling and nurse-led postoperative follow-up care, could reduce the length of total hospital stays, immediate and late postoperative complications, and death events. However, the success of the treatment is “teamwork (surgeon, nurses, social workers, nutritionists, etc.).” Preoperative counseling by a healthcare professional is necessary in patients who have undergone radical gastrectomy for gastric cancer. The experience and expertise of surgeons and surgical techniques could lead to a decrease in late postoperative complications and death of patients after radical gastrectomy for gastric cancer. The absence of neoadjuvant chemotherapy was an independent parameter for worse postoperative complications and death. However, further evidence from prospective or randomized studies is required. The study provided a comparison of different methods of pre and postoperative counseling after radical gastrectomy, which is very important in providing care for patients with gastric cancer.

Abbreviations

NC cohort: Patients received preoperative nurse-led counseling, postoperative nurse-led follow-up care between chemoradiotherapies and follow-up after radical gastrectomy, and received surgeon(s)’ visit every 3 months in follow-up, SC cohort: Patients received preoperative surgeon-led counseling before radical gastrectomy and surgeons visited every 3 months between chemoradiotherapies and during follow-up after radical gastrectomy, RC cohort: Patients did not receive preoperative professional-led counseling before radical gastrectomy and received surgeons visit every 3 months between chemoradiotherapies and during follow-up after radical gastrectomy, CI: confidence interval, PICU: postoperative intensive care unit, SD: standard deviation, Q1: 25th quartile value, Q3: 75th quartile value, ANOVA: Analysis of variance, χ 2-test: chi-squared test, MICU: medical intensive care unit.


tel: +86-13456665123, fax: +86-13456665123

Acknowledgements

The authors are thankful to the nursing, medical, and operative staff of the Affiliated Hospital of Beihua University, Jilin City, Jilin Province, China, and School of Nursing, Beihua University, Jilin City, Jilin Province, China.

  1. Funding information: This study was supported by the Jilin Provincial Department of Science and Technology (No: YDZJ202201ZYTS156).

  2. Author contributions: All authors have read and approved the manuscript for publication. W.W. was the project administrator and contributed to the funding acquisition, supervision, resources, methodology, validation, and literature review. Y.Z. contributed to the investigation, resources, funding acquisition, visualization, software, methodology, and literature review. Y.S. contributed to resources, validation, conceptualization, methodology, funding acquisition, and literature review. Y.L. contributed to the resources, data curation, formal analysis, methodology, funding acquisition, and literature review of the study, and drafted and edited the manuscript for intellectual content. All authors agreed to be accountable for all aspects of this work, ensuring its integrity and accuracy. W.W., Y.Z., and Y.L. confirmed the authenticity of the raw data.

  3. Conflict of interest: The authors declare that they have no conflicts of interest or any competing interest regarding the results and/or discussions reported in this research.

  4. Data availability statement: The data that support the findings of this study are not publicly available because they contain information that could compromise the privacy of research participants, but are available from the corresponding author upon reasonable request.

References

[1] Ning FL, Lyu J, Pei JP, Gu WJ, Zhang NN, Cao SY, et al. The burden and trend of gastric cancer and possible risk factors in five Asian countries from 1990 to 2019. Sci Rep. 2022;12(1):5980.10.1038/s41598-022-10014-4Search in Google Scholar PubMed PubMed Central

[2] Yang L, Kartsonaki C, Yao P, de Martel C, Plummer M, Chapman D, et al. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: A case-cohort study. Lancet Public Health. 2021;6(12):e888–96.10.1016/S2468-2667(21)00164-XSearch in Google Scholar PubMed PubMed Central

[3] Li L, Liu ZH, Cai XF, Jiang QT, Mou YP, Wang YY. Cardia function-preserving surgery and anti-reflux anastomotic method after proximal gastrectomy for gastric cancer: Current status and future perspectives. Front Oncol. 2022;12:1–11.10.3389/fonc.2022.1000719Search in Google Scholar PubMed PubMed Central

[4] Zhang WH, Chen XZ, Yang K, Liu K, Guo DJ, Wang W, et al. Risk factors and survival outcomes for postoperative pulmonary complications in gastric cancer patients. Hepatogastroenterology. 2015;62(139):766–72.Search in Google Scholar

[5] Guerra F, Giuliani G, Formisano G, Bianchi PP, Patriti A, Coratti A. Pancreatic complications after conventional laparoscopic radical gastrectomy versus robotic radical gastrectomy: Systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A. 2018;28(10):1207–15.10.1089/lap.2018.0159Search in Google Scholar PubMed

[6] Liu HD, Wang LJ, Xu ZK. Diagnosis, prevention and treatment of post-operative rare complications after radical gastrectomy for gastric cancer. Chin J Gastrointest Surg. 2023;26(2):138–43.Search in Google Scholar

[7] Yan Y, Jin P, Yu Z, Tang Z, Lu J, Hu Y, et al. Effectiveness of oncology nurse navigator on the incidence of postoperative pulmonary complications in gastric cancer patients undergoing radical gastrectomy. BMC Nurs. 2023;22(1):208.10.1186/s12912-023-01399-2Search in Google Scholar PubMed PubMed Central

[8] Biondi A, Agnes A, Del Coco F, Pozzo C, Strippoli A, D'Ugo D, et al. Preoperative therapy and long-term survival in gastric cancer: One size does not fit all. Surg Oncol. 2018;27(3):575–83.10.1016/j.suronc.2018.07.006Search in Google Scholar PubMed

[9] Guo Y, Ding L, Miao X, Jiang X, Xu T, Xu X, et al. Effects of prehabilitation on postoperative outcomes in frail cancer patients undergoing elective surgery: a systematic review and meta-analysis. Support Care Cancer. 2022;31(1):57.10.1007/s00520-022-07541-1Search in Google Scholar PubMed

[10] Sau-Man Conny C, Wan-Yim I. The effectiveness of nurse-led preoperative assessment clinics for patients receiving elective orthopaedic surgery: A systematic review. J Perianesth Nurs. 2016;31(6):465–74.10.1016/j.jopan.2014.08.147Search in Google Scholar PubMed

[11] Verschuur EM, Steyerberg EW, Tilanus HW, Polinder S, Essink-Bot ML, Tran KT, et al. Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: A randomised trial. Br J Cancer. 2009;100(1):70–6.10.1038/sj.bjc.6604811Search in Google Scholar PubMed PubMed Central

[12] Huang J, Zhang H. Nurse supervised at institutes versus nurse counseling home‑based resistance exercise training for acute pancreatitis. Dig Dis Sci. 2024;69(3):692–701. 10.1007/s10620-023-08241-4.Search in Google Scholar PubMed

[13] Li ZY, Zhao YL, Qian F, Tang B, Luo ZY, Wen Y, et al. Comparison of the postoperative complications between robotic total and distal gastrectomies for gastric cancer using Clavien-Dindo Classification: A propensity score-matched retrospective cohort study of 726 patients. Surg Innovation. 2022;29(5):608–15.10.1177/15533506211047011Search in Google Scholar PubMed

[14] Zhang Y, Yu D, Yang Q, Li W. Diagnostic efficacy of physical examination, preoperative ultrasound, and/or computed tomography in detecting lymph node metastasis: A single-center retrospective analysis of patients with squamous cell carcinoma of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;134(3):386–96.10.1016/j.oooo.2022.05.002Search in Google Scholar PubMed

[15] Samnani SS, Umer MF, Mehdi SH, Farid FN. Impact of Preoperative Counselling on Early Postoperative Mobilization and Its Role in Smooth Recovery. Int Sch Res Not. 2014;2014:250536.10.1155/2014/250536Search in Google Scholar PubMed PubMed Central

[16] Brodersen F, Wagner J, Uzunoglu FG, Petersen-Ewert C. Impact of preoperative patient education on postoperative recovery in abdominal surgery: A systematic review. World J Surg. 2023;47(4):937–47.10.1007/s00268-022-06884-4Search in Google Scholar PubMed PubMed Central

[17] Xu H, Wang W, Li P, Zhang D, Yang L, Xu Z. The key points of prevention for special surgical complications after radical operation of gastric cancer. Chin J Gastrointest Surg. 2017;20(2):152–5.Search in Google Scholar

[18] Zizzo M, Ugoletti L, Manzini L, Castro Ruiz C, Nita GE, Zanelli M, et al. Management of duodenal stump fistula after gastrectomy for malignant disease: A systematic review of the literature. BMC Surg. 2019;19(1):55.10.1186/s12893-019-0520-xSearch in Google Scholar PubMed PubMed Central

[19] Stratilatovas E, Baušys A, Baušys R, Sangaila E. Mortality after gastrectomy: A 10 year single institution experience. Acta Chir Belg. 2015;115(2):123–30.10.1080/00015458.2015.11681081Search in Google Scholar PubMed

Received: 2024-06-17
Revised: 2024-10-26
Accepted: 2024-11-04
Published Online: 2025-01-17

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
  3. Impact of diabetes on long-term survival in elderly liver cancer patients: A retrospective study
  4. Knockdown of CCNB1 alleviates high glucose-triggered trophoblast dysfunction during gestational diabetes via Wnt/β-catenin signaling pathway
  5. Risk factors for severe adverse drug reactions in hospitalized patients
  6. Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with Fonsecaea monophora based on single-cell sequencing
  7. Development and validation of headspace gas chromatography with a flame ionization detector method for the determination of ethanol in the vitreous humor
  8. CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis
  9. Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia
  10. Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway
  11. Comparison of the effectiveness of nurse-led preoperative counseling and postoperative follow-up care vs standard care for patients with gastric cancer
  12. Comparing the therapeutic efficacy of endoscopic minimally invasive surgery and traditional surgery for early-stage breast cancer: A meta-analysis
  13. Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
  14. Association between statin administration and outcome in patients with sepsis: A retrospective study
  15. Exploration of the association between estimated glucose disposal rate and osteoarthritis in middle-aged and older adults: An analysis of NHANES data from 2011 to 2018
  16. A comparative analysis of the binary and multiclass classified chest X-ray images of pneumonia and COVID-19 with ML and DL models
  17. Lysophosphatidic acid 2 alleviates deep vein thrombosis via protective endothelial barrier function
  18. Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
  19. Serum PM20D1 levels are associated with nutritional status and inflammatory factors in gastric cancer patients undergoing early enteral nutrition
  20. Hydromorphone reduced the incidence of emergence agitation after adenotonsillectomy in children with obstructive sleep apnea: A randomized, double-blind study
  21. Vitamin D replacement therapy may regulate sleep habits in patients with restless leg syndrome
  22. The first-line antihypertensive nitrendipine potentiated the therapeutic effect of oxaliplatin by downregulating CACNA1D in colorectal cancer
  23. Health literacy and health-related quality of life: The mediating role of irrational happiness
  24. Modulatory effects of Lycium barbarum polysaccharide on bone cell dynamics in osteoporosis
  25. Mechanism research on inhibition of gastric cancer in vitro by the extract of Pinellia ternata based on network pharmacology and cellular metabolomics
  26. Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study
  27. Clinical analysis of ten cases of HIV infection combined with acute leukemia
  28. Investigating the cardioprotective potential of quercetin against tacrolimus-induced cardiotoxicity in Wistar rats: A mechanistic insights
  29. Clinical observation of probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema in treating mild-to-moderate ulcerative colitis
  30. Diagnostic value of ratio of blood inflammation to coagulation markers in periprosthetic joint infection
  31. Sex-specific associations of sex hormone binding globulin and risk of bladder cancer
  32. Core muscle strength and stability-oriented breathing training reduces inter-recti distance in postpartum women
  33. The ERAS nursing care strategy for patients undergoing transsphenoidal endoscopic pituitary tumor resection: A randomized blinded controlled trial
  34. The serum IL-17A levels in patients with traumatic bowel rupture post-surgery and its predictive value for patient prognosis
  35. Impact of Kolb’s experiential learning theory-based nursing on caregiver burden and psychological state of caregivers of dementia patients
  36. Analysis of serum NLR combined with intraoperative margin condition to predict the prognosis of cervical HSIL patients undergoing LEEP surgery
  37. Commiphora gileadensis ameliorate infertility and erectile dysfunction in diabetic male mice
  38. The correlation between epithelial–mesenchymal transition classification and MMP2 expression of circulating tumor cells and prognosis of advanced or metastatic nasopharyngeal carcinoma
  39. Tetrahydropalmatine improves mitochondrial function in vascular smooth muscle cells of atherosclerosis in vitro by inhibiting Ras homolog gene family A/Rho-associated protein kinase-1 signaling pathway
  40. A cross-sectional study: Relationship between serum oxidative stress levels and arteriovenous fistula maturation in maintenance dialysis patients
  41. A comparative analysis of the impact of repeated administration of flavan 3-ol on brown, subcutaneous, and visceral adipose tissue
  42. Identifying early screening factors for depression in middle-aged and older adults: A cohort study
  43. Perform tumor-specific survival analysis for Merkel cell carcinoma patients undergoing surgical resection based on the SEER database by constructing a nomogram chart
  44. Unveiling the role of CXCL10 in pancreatic cancer progression: A novel prognostic indicator
  45. High-dose preoperative intraperitoneal erythropoietin and intravenous methylprednisolone in acute traumatic spinal cord injuries following decompression surgeries
  46. RAB39B: A novel biomarker for acute myeloid leukemia identified via multi-omics and functional validation
  47. Impact of peripheral conditioning on reperfusion injury following primary percutaneous coronary intervention in diabetic and non-diabetic STEMI patients
  48. Clinical efficacy of azacitidine in the treatment of middle- and high-risk myelodysplastic syndrome in middle-aged and elderly patients: A retrospective study
  49. The effect of ambulatory blood pressure load on mitral regurgitation in continuous ambulatory peritoneal dialysis patients
  50. Expression and clinical significance of ITGA3 in breast cancer
  51. Single-nucleus RNA sequencing reveals ARHGAP28 expression of podocytes as a biomarker in human diabetic nephropathy
  52. rSIG combined with NLR in the prognostic assessment of patients with multiple injuries
  53. Toxic metals and metalloids in collagen supplements of fish and jellyfish origin: Risk assessment for daily intake
  54. Exploring causal relationship between 41 inflammatory cytokines and marginal zone lymphoma: A bidirectional Mendelian randomization study
  55. Gender beliefs and legitimization of dating violence in adolescents
  56. Effect of serum IL-6, CRP, and MMP-9 levels on the efficacy of modified preperitoneal Kugel repair in patients with inguinal hernia
  57. Effect of smoking and smoking cessation on hematological parameters in polycythemic patients
  58. Pathogen surveillance and risk factors for pulmonary infection in patients with lung cancer: A retrospective single-center study
  59. Necroptosis of hippocampal neurons in paclitaxel chemotherapy-induced cognitive impairment mediates microglial activation via TLR4/MyD88 signaling pathway
  60. Celastrol suppresses neovascularization in rat aortic vascular endothelial cells stimulated by inflammatory tenocytes via modulating the NLRP3 pathway
  61. Cord-lamina angle and foraminal diameter as key predictors of C5 palsy after anterior cervical decompression and fusion surgery
  62. GATA1: A key biomarker for predicting the prognosis of patients with diffuse large B-cell lymphoma
  63. Influencing factors of false lumen thrombosis in type B aortic dissection: A single-center retrospective study
  64. MZB1 regulates the immune microenvironment and inhibits ovarian cancer cell migration
  65. Integrating experimental and network pharmacology to explore the pharmacological mechanisms of Dioscin against glioblastoma
  66. Trends in research on preterm birth in twin pregnancy based on bibliometrics
  67. Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma
  68. Single-cell transcriptomic analysis identifies a stress response Schwann cell subtype
  69. Acute pancreatitis risk in the diagnosis and management of inflammatory bowel disease: A critical focus
  70. Effect of subclinical esketamine on NLRP3 and cognitive dysfunction in elderly ischemic stroke patients
  71. Interleukin-37 mediates the anti-oral tumor activity in oral cancer through STAT3
  72. CA199 and CEA expression levels, and minimally invasive postoperative prognosis analysis in esophageal squamous carcinoma patients
  73. Efficacy of a novel drainage catheter in the treatment of CSF leak after posterior spine surgery: A retrospective cohort study
  74. Comprehensive biomedicine assessment of Apteranthes tuberculata extracts: Phytochemical analysis and multifaceted pharmacological evaluation in animal models
  75. Relation of time in range to severity of coronary artery disease in patients with type 2 diabetes: A cross-sectional study
  76. Dopamine attenuates ethanol-induced neuronal apoptosis by stimulating electrical activity in the developing rat retina
  77. Correlation between albumin levels during the third trimester and the risk of postpartum levator ani muscle rupture
  78. Factors associated with maternal attention and distraction during breastfeeding and childcare: A cross-sectional study in the west of Iran
  79. Mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experiments
  80. The law on oncological oblivion in the Italian and European context: How to best uphold the cancer patients’ rights to privacy and self-determination?
  81. The prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and prognostic nutritional index for survival in patients with colorectal cancer
  82. Factors affecting the measurements of peripheral oxygen saturation values in healthy young adults
  83. Comparison and correlations between findings of hysteroscopy and vaginal color Doppler ultrasonography for detection of uterine abnormalities in patients with recurrent implantation failure
  84. The effects of different types of RAGT on balance function in stroke patients with low levels of independent walking in a convalescent rehabilitation hospital
  85. Causal relationship between asthma and ankylosing spondylitis: A bidirectional two-sample univariable and multivariable Mendelian randomization study
  86. Correlations of health literacy with individuals’ understanding and use of medications in Southern Taiwan
  87. Correlation of serum calprotectin with outcome of acute cerebral infarction
  88. Comparison of computed tomography and guided bronchoscopy in the diagnosis of pulmonary nodules: A systematic review and meta-analysis
  89. Curdione protects vascular endothelial cells and atherosclerosis via the regulation of DNMT1-mediated ERBB4 promoter methylation
  90. The identification of novel missense variant in ChAT gene in a patient with gestational diabetes denotes plausible genetic association
  91. Molecular genotyping of multi-system rare blood types in foreign blood donors based on DNA sequencing and its clinical significance
  92. Exploring the role of succinyl carnitine in the association between CD39⁺ CD4⁺ T cell and ulcerative colitis: A Mendelian randomization study
  93. Dexmedetomidine suppresses microglial activation in postoperative cognitive dysfunction via the mmu-miRNA-125/TRAF6 signaling axis
  94. Analysis of serum metabolomics in patients with different types of chronic heart failure
  95. Diagnostic value of hematological parameters in the early diagnosis of acute cholecystitis
  96. Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease
  97. Decrease in CD4 and CD8 lymphocytes are predictors of severe clinical picture and unfavorable outcome of the disease in patients with COVID-19
  98. METTL3 blocked the progression of diabetic retinopathy through m6A-modified SOX2
  99. The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors
  100. Exploring cerebrospinal fluid metabolites, cognitive function, and brain atrophy: Insights from Mendelian randomization
  101. Development and validation of potential molecular subtypes and signatures of ocular sarcoidosis based on autophagy-related gene analysis
  102. Widespread venous thrombosis: Unveiling a complex case of Behçet’s disease with a literature perspective
  103. Uterine fibroid embolization: An analysis of clinical outcomes and impact on patients’ quality of life
  104. Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head
  105. Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
  106. Enhancing chronic back pain management: A comparative study of ultrasound–MRI fusion guidance for paravertebral nerve block
  107. Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway
  108. Electroacupuncture-induced reduction of myocardial ischemia–reperfusion injury via FTO-dependent m6A methylation modulation
  109. Hemorrhoids and cardiovascular disease: A bidirectional Mendelian randomization study
  110. Cell-free adipose extract inhibits hypertrophic scar formation through collagen remodeling and antiangiogenesis
  111. HALP score in Demodex blepharitis: A case–control study
  112. Assessment of SOX2 performance as a marker for circulating cancer stem-like cells (CCSCs) identification in advanced breast cancer patients using CytoTrack system
  113. Risk and prognosis for brain metastasis in primary metastatic cervical cancer patients: A population-based study
  114. Comparison of the two intestinal anastomosis methods in pediatric patients
  115. Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer
  116. Endotoxin tolerance inhibits NLRP3 inflammasome activation in macrophages of septic mice by restoring autophagic flux through TRIM26
  117. Review Articles
  118. The effects of enhanced external counter-pulsation on post-acute sequelae of COVID-19: A narrative review
  119. Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments
  120. Microscopic changes and gross morphology of placenta in women affected by gestational diabetes mellitus in dietary treatment: A systematic review
  121. Review of mechanisms and frontier applications in IL-17A-induced hypertension
  122. Research progress on the correlation between islet amyloid peptides and type 2 diabetes mellitus
  123. The safety and efficacy of BCG combined with mitomycin C compared with BCG monotherapy in patients with non-muscle-invasive bladder cancer: A systematic review and meta-analysis
  124. The application of augmented reality in robotic general surgery: A mini-review
  125. The effect of Greek mountain tea extract and wheat germ extract on peripheral blood flow and eicosanoid metabolism in mammals
  126. Neurogasobiology of migraine: Carbon monoxide, hydrogen sulfide, and nitric oxide as emerging pathophysiological trinacrium relevant to nociception regulation
  127. Plant polyphenols, terpenes, and terpenoids in oral health
  128. Laboratory medicine between technological innovation, rights safeguarding, and patient safety: A bioethical perspective
  129. End-of-life in cancer patients: Medicolegal implications and ethical challenges in Europe
  130. The maternal factors during pregnancy for intrauterine growth retardation: An umbrella review
  131. Intra-abdominal hypertension/abdominal compartment syndrome of pediatric patients in critical care settings
  132. PI3K/Akt pathway and neuroinflammation in sepsis-associated encephalopathy
  133. Screening of Group B Streptococcus in pregnancy: A systematic review for the laboratory detection
  134. Giant borderline ovarian tumours – review of the literature
  135. Leveraging artificial intelligence for collaborative care planning: Innovations and impacts in shared decision-making – A systematic review
  136. Cholera epidemiology analysis through the experience of the 1973 Naples epidemic
  137. Case Reports
  138. Delayed graft function after renal transplantation
  139. Semaglutide treatment for type 2 diabetes in a patient with chronic myeloid leukemia: A case report and review of the literature
  140. Diverse electrophysiological demyelinating features in a late-onset glycogen storage disease type IIIa case
  141. Giant right atrial hemangioma presenting with ascites: A case report
  142. Laser excision of a large granular cell tumor of the vocal cord with subglottic extension: A case report
  143. Rapid Communication
  144. Biological properties of valve materials using RGD and EC
  145. Letter to the Editor
  146. Role of enhanced external counterpulsation in long COVID
  147. Expression of Concern
  148. Expression of concern “A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma”
  149. Expression of concern “Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway”
  150. Expression of concern “circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8”
  151. Corrigendum
  152. Corrigendum to “Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism”
  153. Corrigendum to “Comparing the therapeutic efficacy of endoscopic minimally invasive surgery and traditional surgery for early-stage breast cancer: A meta-analysis”
  154. Corrigendum to “The progress of autoimmune hepatitis research and future challenges”
  155. Retraction
  156. Retraction of “miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway”
  157. Special Issue Advancements in oncology: bridging clinical and experimental research - Part II
  158. Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
  159. Lathyrol affects the expression of AR and PSA and inhibits the malignant behavior of RCC cells
  160. The era of increasing cancer survivorship: Trends in fertility preservation, medico-legal implications, and ethical challenges
  161. Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ
  162. Meta-analysis of clinical efficacy and safety of immunotherapy combined with chemotherapy in non-small cell lung cancer
  163. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part IV
  164. Exploration of mRNA-modifying METTL3 oncogene as momentous prognostic biomarker responsible for colorectal cancer development
  165. Special Issue The evolving saga of RNAs from bench to bedside - Part III
  166. Interaction and verification of ferroptosis-related RNAs Rela and Stat3 in promoting sepsis-associated acute kidney injury
  167. Special Issue Exploring the biological mechanism of human diseases based on MultiOmics Technology - Part II
  168. Dynamic changes in lactate-related genes in microglia and their role in immune cell interactions after ischemic stroke
  169. A prognostic model correlated with fatty acid metabolism in Ewing’s sarcoma based on bioinformatics analysis
  170. Special Issue Diabetes
  171. Nutritional risk assessment and nutritional support in children with congenital diabetes during surgery
  172. Correlation of the differential expressions of RANK, RANKL, and OPG with obesity in the elderly population in Xinjiang
  173. Special Issue Biomarker Discovery and Precision Medicine
  174. CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2024-1098/html
Scroll to top button